UA96775C2 - Process for the preparation of pleuromutilins - Google Patents

Process for the preparation of pleuromutilins

Info

Publication number
UA96775C2
UA96775C2 UAA200904312A UAA200904312A UA96775C2 UA 96775 C2 UA96775 C2 UA 96775C2 UA A200904312 A UAA200904312 A UA A200904312A UA A200904312 A UAA200904312 A UA A200904312A UA 96775 C2 UA96775 C2 UA 96775C2
Authority
UA
Ukraine
Prior art keywords
preparation
sulfanyl
butyryl
acetyl
amino
Prior art date
Application number
UAA200904312A
Other languages
English (en)
Ukrainian (uk)
Inventor
Ингольф МАХЕР
Андреас Бергер
Мартин ДЕКРИСТОФОРО
Original Assignee
Набрива Тэрапэвтикс Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Набрива Тэрапэвтикс Аг filed Critical Набрива Тэрапэвтикс Аг
Publication of UA96775C2 publication Critical patent/UA96775C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Изобретение касается способа получения 14-О-[(N-(3-метил-2-аминобутирилпиперидинил)сульфанил)ацетил]мутилинов формулы (I), пригодных для широкомасштабного производства продуктов высокой степени чистоты, в которых атом углерода в пиперидиновом кольце, связанный с атомом серы, находится или в (S)-конфигурации, или в (R)-конфигурации, а также к новой кристаллической форме 14-O-[(N-(3-метил-2-аминобутирилпиперидинил)сульфанил)ацетил]мутилина гидрохлорида.I
UAA200904312A 2006-10-05 2007-10-03 Process for the preparation of pleuromutilins UA96775C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06121852A EP1908750A1 (en) 2006-10-05 2006-10-05 Process for the preparation of pleuromutilins

Publications (1)

Publication Number Publication Date
UA96775C2 true UA96775C2 (en) 2011-12-12

Family

ID=37781773

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200904312A UA96775C2 (en) 2006-10-05 2007-10-03 Process for the preparation of pleuromutilins

Country Status (21)

Country Link
US (2) US8334389B2 (ru)
EP (3) EP1908750A1 (ru)
JP (1) JP5557530B2 (ru)
KR (1) KR101577675B1 (ru)
CN (1) CN101595090B (ru)
AT (1) ATE523490T1 (ru)
AU (1) AU2007304867B2 (ru)
BR (1) BRPI0719205B8 (ru)
CA (1) CA2665347C (ru)
ES (1) ES2373341T3 (ru)
HR (1) HRP20090192B1 (ru)
IL (1) IL197970A (ru)
MX (1) MX2009003681A (ru)
MY (1) MY146357A (ru)
NO (1) NO341868B1 (ru)
NZ (1) NZ576034A (ru)
RU (1) RU2512591C2 (ru)
TW (1) TWI432416B (ru)
UA (1) UA96775C2 (ru)
WO (1) WO2008040043A1 (ru)
ZA (1) ZA200902159B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
EP2399904A1 (en) * 2010-05-26 2011-12-28 Nabriva Therapeutics AG Process for the preparation of pleuromutilins
CN104803911B (zh) * 2014-01-23 2018-01-05 中国科学院上海药物研究所 一类截短侧耳素化合物、其药物组合物、合成方法与用途
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3405632A1 (de) * 1984-02-17 1985-08-22 Sandoz-Patent-GmbH, 7850 Lörrach Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
GB9918037D0 (en) 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
PE20020676A1 (es) * 2000-09-13 2002-08-27 Biochemie Gmbh Compuestos de mutilina como antibacterianos
ES2295657T3 (es) * 2002-07-24 2008-04-16 Nabriva Therapeutics Forschungs Gmbh Derivados de pleuromutilina como antimicrobianos.

Also Published As

Publication number Publication date
US8334389B2 (en) 2012-12-18
NO20091261L (no) 2009-06-30
HRP20090192B1 (hr) 2016-05-06
AU2007304867A1 (en) 2008-04-10
EP2069301B1 (en) 2011-09-07
CN101595090A (zh) 2009-12-02
ES2373341T3 (es) 2012-02-02
BRPI0719205B8 (pt) 2021-05-25
TWI432416B (zh) 2014-04-01
KR20090086203A (ko) 2009-08-11
JP2010505771A (ja) 2010-02-25
MY146357A (en) 2012-08-15
IL197970A0 (en) 2009-12-24
WO2008040043A1 (en) 2008-04-10
CA2665347C (en) 2017-02-14
TW200831461A (en) 2008-08-01
EP2272829A2 (en) 2011-01-12
ZA200902159B (en) 2010-06-30
NZ576034A (en) 2011-07-29
US20090253748A1 (en) 2009-10-08
US8624033B2 (en) 2014-01-07
IL197970A (en) 2014-09-30
ATE523490T1 (de) 2011-09-15
BRPI0719205B1 (pt) 2020-04-28
JP5557530B2 (ja) 2014-07-23
MX2009003681A (es) 2009-07-16
HK1139135A1 (en) 2010-09-10
US20130053571A1 (en) 2013-02-28
EP1908750A1 (en) 2008-04-09
EP2272829A3 (en) 2011-02-09
CA2665347A1 (en) 2008-04-10
NO341868B1 (no) 2018-02-12
KR101577675B1 (ko) 2015-12-15
EP2069301A1 (en) 2009-06-17
RU2512591C2 (ru) 2014-04-10
HRP20090192A2 (en) 2009-08-31
CN101595090B (zh) 2014-12-24
BRPI0719205A2 (pt) 2014-02-04
RU2009116945A (ru) 2010-11-10
AU2007304867B2 (en) 2013-02-07

Similar Documents

Publication Publication Date Title
MX2009005440A (es) Procedimiento para la produccion de derivados de fenilalanina que tienen estructuras de base de quinazolinodiona e intermediarios para la produccion.
UA80834C2 (en) Method of synthesising ivabradine and the salts thereof for addition to a pharmaceutically acceptable acid
NZ606001A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
JO2807B1 (en) A new process for the synthesis of ivabradine and its addition salts with pharmaceutically acceptable acid.
MX2011006357A (es) Proceso para la sintesis de di- u oligosacaridos de l-fucosilo y nuevos derivados de 2,3,4 tribencil-fucosilo, sus intermediarios.
MY138452A (en) Novel process for synthesizing and a novel crystal form of agomelatine as well as pharmaceutical preparations containing these
NZ595591A (en) Processes for the preparation of morphinane and morphinone compounds
SG170794A1 (en) Process for preparation of hiv protease inhibitors
SI2019114T1 (sl) Postopek za pripravo drospirenona
GEP20247626B (en) Industrial process for the preparation of high purity estetrol
MY146357A (en) Process for the preparation of pleuromutilins
MY150014A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MY169295A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
IL200811A0 (en) Methods for the preparation of n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives
MX2013000294A (es) Intermedios y procedimiento de preparación de un inhibidor específico de la trombina.
UA74114U (ru) Производные 5-гидрокси-4-аминометил-1-циклогексил (или циклогептил)-3-алкоксикарбонилиндолов, их фармацевтически приемлемые соли, которые имеют противовирусную активность
MX2010001961A (es) Procedimiento para la preparacion de derivados de 2,2-difluoroetilamina mediante hidrogenacion de amida.
JO2782B1 (en) A new process for the synthesis of ivabradine and its addition salts with pharmaceutically acceptable acid.
TW200801259A (en) Production process for high purity polycrystal silicon and production apparatus for the same
MX2010001512A (es) Nuevo procedimiento de preparacion.
WO2008090819A1 (ja) 二環性プロリン化合物の製造方法
NZ592831A (en) Stereoselective synthesis of piperidine derivatives
IN2012DN02828A (ru)
NZ589496A (en) Processes and compounds for the preparation of normorphinans
TW200738650A (en) Process for synthesis of aryloxy diaminopyrimidines